ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.51 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns PRQR stock?
Hedge funds tracked by Rallies that own PRQR include Point72 Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ProQR Therapeutics N.V. Ordinary Shares.
PRQR Key Metrics
Key financial metrics for PRQR
Metric
Value
Price
$1.51
Market Cap
$159.10M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$4.62
52-Week Low
$1.07
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding PRQR
Point72 Asset holds 750.00K shares of PRQR, changed -49.71% as of Mar 31, 2025.
Hedge funds tracked by Rallies that own PRQR include Point72 Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ProQR Therapeutics N.V. Ordinary Shares.
Does Rallies show 13F holders for PRQR?
Yes. Rallies tracks hedge fund and 13F ownership data for PRQR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PRQR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRQR. It does not provide personalized investment advice.
